Sheldon L. Koenig
2021 - Esperion Therapeutics
Compensation breakdown
| Non-Equity Incentive Plan | $150,000 |
|---|---|
| Option Awards | $5,427,619 |
| Salary | $565,909 |
| Stock Awards | $1,619,698 |
| Other | $13,000 |
| Total | $7,776,226 |
Koenig received $5.4M in option awards, accounting for 70% of the total pay in 2021.
Koenig also received $150K in non-equity incentive plan, $565.9K in salary, $1.6M in stock awards and $13K in other compensation.
Rankings
In 2021, Sheldon L. Koenig's compensation ranked 1,506th out of 12,415 executives tracked by ExecPay. In other words, Koenig earned more than 87.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,506 out of 12,415 | 88th |
Division Manufacturing | 545 out of 5,505 | 90th |
Major group Chemicals And Allied Products | 207 out of 2,375 | 91st |
Industry group Drugs | 172 out of 2,096 | 92nd |
Industry Pharmaceutical Preparations | 118 out of 1,546 | 92nd |
Pay ratio
| Sheldon L. Koenig's Pay | $7,776,226 |
|---|---|
| Median Employee's Pay | $217,116 |
| Pay Ratio | 36to 1 |
In 2021, the annual total compensation of Sheldon L. Koenig was $7,776,226.
The annual total compensation of the median employee at Esperion Therapeutics was $217,116.
The ratio of Sheldon L. Koenig's pay to the pay of median employee was therefore 36 to one.
Koenig's colleagues
We found four more compensation records of executives who worked with Sheldon L. Koenig at Esperion Therapeutics in 2021.
News
April 11, 2024
April 13, 2023
April 14, 2022
April 20, 2020